Administration for Strategic Preparedness and Response—Office of Strategy, Policy, Planning, and Requirements Generic Clearance for the National Strategy for a Resilient Public Health Supply Chain
Administration for Strategic Preparedness and ResponseâOffice of Strategy, Policy, Planning, and Requirements Generic Clearance for the National Strategy for a Resilient Public Health Supply Chain
Revision of a currently approved collection
No
Regular
Approved with change
04/15/2026
02/27/2026
The agency will submit individual collections (GenICs) under this generic clearance to OMB.
These submissions will include the actual study instruments along with a memo describing the
specific study goal, the study design, any incentives to be used, coordination with relevant
federal offices and agencies (including those outside of HHS) for specific GenICs, and the
sampling and analysis plans (as applicable).
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
04/30/2029
36 Months From Approved
04/30/2026
32,800
0
32,800
358,934
0
358,934
23,226,620
0
23,226,620
As directed by Executive Order 14001, The National Strategy for a Resilient Public Health Supply Chain (The National Strategy) provides a strategic approach to design, build, and sustain a long-term capability in the United States to manufacture supplies for future pandemics and biological threats. The Administration for Strategic Preparedness and Response at the Department of Health and Human Services is leading an interagency team in implementing the National Strategy and is requesting a generic clearance for purposes of implementation to: gain a better understanding of the public health supply chain; develop future strategic goals and recommendations for building immediate and long-term resilience through increased visibility, agility, and robustness in the public health supply chain to prepare for and mitigate future public health emergencies; and to ensure ASPR, HHS, and the broader U.S. government have current data and information to inform program and policy decision-making.
Formative research and assessment are the main objectives of the activities included in this clearance. The participants will include, but not be limited to, SLTTs, trade groups and associations, mixed cross-sector audiences, non-governmental organizations, manufacturers, academia, healthcare providers and facilities, and local communities, labor unions, workforce training providers, organizations, and state and local workforce boards.
EO: EO 14001 Name/Subject of EO: A Sustainable Public Health Supply Chain
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
0990-0488 Generic Submission Template.docx
NEJM 2026_Substandard Generic Drugs (1).pdf